CollPlant Biotechnologies Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLGN research report →
Companywww.collplant.com
CollPlant Biotechnologies Ltd. , a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.
- CEO
- Yehiel Tal
- IPO
- 2018
- Employees
- 57
- HQ
- Rehovot, IL
Price Chart
Valuation
- Market Cap
- $5.50M
- P/E
- -0.50
- P/S
- 2.32
- P/B
- 0.95
- EV/EBITDA
- -0.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 26.32%
- Op Margin
- -484.31%
- Net Margin
- -484.56%
- ROE
- -114.07%
- ROIC
- -128.63%
Growth & Income
- Revenue
- $2.37M · 360.39%
- Net Income
- $-11,489,000 · 30.83%
- EPS
- $-0.94 · 35.17%
- Op Income
- $-11,483,000
- FCF YoY
- 35.19%
Performance & Tape
- 52W High
- $4.98
- 52W Low
- $0.27
- 50D MA
- $0.47
- 200D MA
- $1.57
- Beta
- 0.64
- Avg Volume
- 86.90K
Get TickerSpark's AI analysis on CLGN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Evans Hugh M | other | 0 |
| Mar 18, 26 | Evans Hugh M | other | 0 |
| Mar 18, 26 | Evans Hugh M | other | 0 |
| Mar 18, 26 | Evans Hugh M | other | 0 |
| May 2, 23 | Evans Hugh M | other | 24,000 |
| Mar 19, 26 | Tal Yehiel | other | 0 |
| Mar 19, 26 | Tal Yehiel | other | 0 |
| May 2, 23 | Tal Yehiel | other | 100,000 |
| May 18, 20 | Tal Yehiel | other | 37,800 |
| Mar 18, 26 | Lask Alisa | other | 0 |
Our CLGN Coverage
We haven't published any research on CLGN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLGN Report →